InvestorsHub Logo
Followers 8
Posts 1204
Boards Moderated 0
Alias Born 07/21/2009

Re: None

Wednesday, 01/09/2019 12:40:52 PM

Wednesday, January 09, 2019 12:40:52 PM

Post# of 59549
I hope with some of the new board members we can finally get this moving in the right direction. John Hollister has been the key.

John Hollister brings over 25 years of leadership experience in large pharmaceuticals, biotech, and medical device companies. He has extensive experience in all aspects of commercialization in the healthcare industry, including significant involvement with multiple products successfully undergoing review by the FDA. Most recently, Mr. Hollister served as CEO of NuLife Sciences, Inc. (OTCQB: NULF) and CEO of NEMUS Bioscience (OTCQB: NMUS). Prior to NEMUS, he was vice president of marketing for Tethys Bioscience, a diabetes diagnostic company. Earlier in his career he was the CEO and chairman of EEG Spectrum, an EEG device manufacturer. John began his career working for SmithKline Beecham and Amgen. Mr. Hollister earned his B.A.in economics from Stanford University and his MBA from Claremont’s Peter F. Drucker Graduate School of Management. He serves as a board member for the Brain and Behavior Research Foundation (formerly NARSAD), the world’s leading charity for brain and behavior research.